Potassium in PDB 8cj7: HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Protein crystallography data
The structure of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor, PDB code: 8cj7
was solved by
J.Sandmark,
M.Ek,
L.Ripa,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
90.19 /
1.51
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
95.977,
84.062,
96.132,
90,
110.25,
90
|
R / Rfree (%)
|
20.6 /
22.7
|
Other elements in 8cj7:
The structure of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor also contains other interesting chemical elements:
Potassium Binding Sites:
The binding sites of Potassium atom in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
(pdb code 8cj7). This binding sites where shown within
5.0 Angstroms radius around Potassium atom.
In total 6 binding sites of Potassium where determined in the
HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor, PDB code: 8cj7:
Jump to Potassium binding site number:
1;
2;
3;
4;
5;
6;
Potassium binding site 1 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 1 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 1 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:K801
b:9.6
occ:1.00
|
O
|
A:ASP612
|
2.6
|
7.8
|
1.0
|
O
|
A:LEU634
|
2.7
|
8.9
|
1.0
|
OG
|
A:SER633
|
2.7
|
10.9
|
1.0
|
O
|
A:HIS614
|
2.7
|
5.8
|
1.0
|
O
|
A:ASP610
|
2.8
|
8.2
|
1.0
|
OD1
|
A:ASP610
|
2.9
|
8.0
|
1.0
|
CG
|
A:ASP610
|
3.3
|
8.2
|
1.0
|
C
|
A:ASP610
|
3.5
|
8.6
|
1.0
|
C
|
A:LEU634
|
3.7
|
9.7
|
1.0
|
C
|
A:HIS614
|
3.7
|
9.6
|
1.0
|
C
|
A:ASP612
|
3.7
|
7.9
|
1.0
|
CB
|
A:ASP610
|
3.8
|
7.0
|
1.0
|
N
|
A:LEU634
|
3.9
|
6.1
|
1.0
|
N
|
A:ASP612
|
3.9
|
4.7
|
1.0
|
CB
|
A:SER633
|
3.9
|
7.2
|
1.0
|
CB
|
A:HIS635
|
3.9
|
6.1
|
1.0
|
OD2
|
A:ASP610
|
4.0
|
10.6
|
1.0
|
N
|
A:TRP611
|
4.2
|
5.8
|
1.0
|
C
|
A:TRP611
|
4.2
|
8.4
|
1.0
|
CA
|
A:HIS615
|
4.3
|
7.0
|
1.0
|
ND1
|
A:HIS635
|
4.3
|
10.6
|
1.0
|
CA
|
A:ASP612
|
4.3
|
5.9
|
1.0
|
CA
|
A:ASP610
|
4.3
|
6.3
|
1.0
|
CA
|
A:SER633
|
4.3
|
5.7
|
1.0
|
N
|
A:HIS615
|
4.4
|
6.4
|
1.0
|
CB
|
A:ASP612
|
4.4
|
5.1
|
1.0
|
CA
|
A:TRP611
|
4.4
|
7.2
|
1.0
|
N
|
A:HIS614
|
4.4
|
8.0
|
1.0
|
C
|
A:SER633
|
4.4
|
9.9
|
1.0
|
N
|
A:GLY616
|
4.4
|
7.8
|
1.0
|
CA
|
A:HIS635
|
4.5
|
7.3
|
1.0
|
O
|
A:HOH931
|
4.5
|
6.5
|
1.0
|
N
|
A:HIS635
|
4.5
|
8.6
|
1.0
|
CA
|
A:LEU634
|
4.5
|
5.6
|
1.0
|
CG
|
A:HIS635
|
4.6
|
8.7
|
1.0
|
OH
|
A:TYR631
|
4.7
|
10.1
|
1.0
|
C
|
A:VAL613
|
4.7
|
10.6
|
1.0
|
C
|
A:HIS615
|
4.7
|
9.7
|
1.0
|
CA
|
A:HIS614
|
4.7
|
7.5
|
1.0
|
CE1
|
A:HIS573
|
4.7
|
7.5
|
1.0
|
N
|
A:VAL613
|
4.8
|
6.1
|
1.0
|
ND1
|
A:HIS573
|
4.8
|
9.8
|
1.0
|
O
|
A:TRP611
|
4.9
|
8.9
|
1.0
|
|
Potassium binding site 2 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 2 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 2 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:K802
b:13.9
occ:1.00
|
O
|
A:PHE623
|
2.6
|
12.7
|
1.0
|
O
|
A:VAL629
|
2.6
|
11.0
|
1.0
|
O
|
A:HOH912
|
2.7
|
12.3
|
1.0
|
O
|
A:ASP626
|
2.8
|
15.8
|
1.0
|
O
|
A:TYR662
|
2.9
|
11.0
|
1.0
|
O
|
A:HOH1049
|
3.0
|
10.0
|
1.0
|
C
|
A:PHE623
|
3.5
|
13.3
|
1.0
|
CB
|
A:PHE623
|
3.6
|
10.0
|
1.0
|
C
|
A:TYR662
|
3.7
|
12.9
|
1.0
|
CB
|
A:TYR662
|
3.7
|
12.5
|
1.0
|
C
|
A:VAL629
|
3.8
|
11.1
|
1.0
|
C
|
A:ASP626
|
4.0
|
17.0
|
1.0
|
CA
|
A:PHE623
|
4.2
|
8.3
|
1.0
|
CA
|
A:TYR662
|
4.3
|
11.7
|
1.0
|
N
|
A:TYR631
|
4.3
|
6.5
|
1.0
|
N
|
A:GLU624
|
4.4
|
11.0
|
1.0
|
N
|
A:ASP626
|
4.5
|
14.9
|
1.0
|
CB
|
A:ASP626
|
4.5
|
17.7
|
1.0
|
N
|
A:ASN663
|
4.5
|
10.3
|
1.0
|
CA
|
A:ASP626
|
4.5
|
15.3
|
1.0
|
CA
|
A:LEU630
|
4.6
|
7.0
|
1.0
|
CA
|
A:GLU624
|
4.6
|
11.2
|
1.0
|
N
|
A:LEU630
|
4.6
|
7.3
|
1.0
|
CB
|
A:TYR631
|
4.7
|
7.1
|
1.0
|
C
|
A:GLU624
|
4.8
|
14.2
|
1.0
|
O
|
A:GLU624
|
4.8
|
13.6
|
1.0
|
CA
|
A:ASN663
|
4.9
|
9.6
|
1.0
|
CA
|
A:VAL629
|
4.9
|
9.2
|
1.0
|
C
|
A:LEU630
|
4.9
|
11.6
|
1.0
|
CB
|
A:ASN663
|
4.9
|
12.4
|
1.0
|
O
|
A:GLY659
|
4.9
|
23.9
|
1.0
|
CG
|
A:PHE623
|
4.9
|
10.6
|
1.0
|
CG
|
A:TYR662
|
5.0
|
14.4
|
1.0
|
|
Potassium binding site 3 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 3 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 3 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:K801
b:12.8
occ:1.00
|
O
|
B:ASP612
|
2.5
|
11.9
|
1.0
|
O
|
B:LEU634
|
2.7
|
11.1
|
1.0
|
O
|
B:HIS614
|
2.7
|
11.8
|
1.0
|
OG
|
B:SER633
|
2.8
|
14.4
|
1.0
|
O
|
B:ASP610
|
2.8
|
8.7
|
1.0
|
OD1
|
B:ASP610
|
2.8
|
9.5
|
1.0
|
CG
|
B:ASP610
|
3.3
|
10.6
|
1.0
|
C
|
B:ASP610
|
3.5
|
11.1
|
1.0
|
C
|
B:ASP612
|
3.6
|
11.6
|
1.0
|
C
|
B:LEU634
|
3.7
|
12.8
|
1.0
|
C
|
B:HIS614
|
3.7
|
13.3
|
1.0
|
N
|
B:ASP612
|
3.7
|
7.9
|
1.0
|
CB
|
B:ASP610
|
3.8
|
10.2
|
1.0
|
N
|
B:LEU634
|
3.9
|
11.1
|
1.0
|
CB
|
B:HIS635
|
4.0
|
10.5
|
1.0
|
CB
|
B:SER633
|
4.0
|
8.4
|
1.0
|
OD2
|
B:ASP610
|
4.0
|
12.1
|
1.0
|
CA
|
B:ASP612
|
4.1
|
7.1
|
1.0
|
N
|
B:TRP611
|
4.2
|
9.5
|
1.0
|
C
|
B:TRP611
|
4.2
|
13.2
|
1.0
|
CB
|
B:ASP612
|
4.2
|
6.9
|
1.0
|
CA
|
B:ASP610
|
4.3
|
8.8
|
1.0
|
CA
|
B:HIS615
|
4.3
|
10.9
|
1.0
|
ND1
|
B:HIS635
|
4.3
|
15.9
|
1.0
|
CA
|
B:SER633
|
4.3
|
8.3
|
1.0
|
CA
|
B:TRP611
|
4.3
|
11.0
|
1.0
|
N
|
B:HIS615
|
4.4
|
10.8
|
1.0
|
N
|
B:HIS614
|
4.4
|
11.6
|
1.0
|
O
|
B:HOH923
|
4.4
|
10.4
|
1.0
|
CA
|
B:HIS635
|
4.5
|
8.8
|
1.0
|
C
|
B:SER633
|
4.5
|
11.7
|
1.0
|
N
|
B:HIS635
|
4.5
|
10.6
|
1.0
|
N
|
B:GLY616
|
4.5
|
8.0
|
1.0
|
CA
|
B:LEU634
|
4.5
|
10.9
|
1.0
|
CG
|
B:HIS635
|
4.6
|
14.0
|
1.0
|
C
|
B:VAL613
|
4.7
|
13.1
|
1.0
|
N
|
B:VAL613
|
4.7
|
9.2
|
1.0
|
CE1
|
B:HIS573
|
4.7
|
12.6
|
1.0
|
CA
|
B:HIS614
|
4.7
|
10.7
|
1.0
|
C
|
B:HIS615
|
4.8
|
12.3
|
1.0
|
OH
|
B:TYR631
|
4.8
|
10.3
|
1.0
|
ND1
|
B:HIS573
|
4.8
|
13.6
|
1.0
|
O
|
B:TRP611
|
4.9
|
10.7
|
1.0
|
|
Potassium binding site 4 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 4 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 4 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:K802
b:16.2
occ:1.00
|
O
|
B:PHE623
|
2.6
|
14.6
|
1.0
|
O
|
B:VAL629
|
2.6
|
14.8
|
1.0
|
O
|
B:HOH904
|
2.8
|
15.8
|
1.0
|
O
|
B:ASP626
|
2.8
|
18.7
|
1.0
|
O
|
B:TYR662
|
2.9
|
15.3
|
1.0
|
O
|
B:HOH1051
|
3.0
|
11.8
|
1.0
|
C
|
B:PHE623
|
3.5
|
15.3
|
1.0
|
C
|
B:TYR662
|
3.6
|
16.3
|
1.0
|
CB
|
B:TYR662
|
3.6
|
14.6
|
1.0
|
CB
|
B:PHE623
|
3.7
|
11.0
|
1.0
|
C
|
B:VAL629
|
3.8
|
15.3
|
1.0
|
C
|
B:ASP626
|
4.0
|
20.5
|
1.0
|
CA
|
B:TYR662
|
4.2
|
14.0
|
1.0
|
CA
|
B:PHE623
|
4.3
|
10.1
|
1.0
|
N
|
B:TYR631
|
4.3
|
12.4
|
1.0
|
N
|
B:GLU624
|
4.4
|
13.7
|
1.0
|
N
|
B:ASN663
|
4.5
|
12.7
|
1.0
|
N
|
B:ASP626
|
4.5
|
19.5
|
1.0
|
CA
|
B:ASP626
|
4.5
|
19.4
|
1.0
|
CB
|
B:ASP626
|
4.5
|
21.9
|
1.0
|
CA
|
B:LEU630
|
4.6
|
10.7
|
1.0
|
CA
|
B:GLU624
|
4.6
|
13.9
|
1.0
|
N
|
B:LEU630
|
4.6
|
11.3
|
1.0
|
CB
|
B:TYR631
|
4.7
|
12.3
|
1.0
|
C
|
B:GLU624
|
4.7
|
17.5
|
1.0
|
O
|
B:GLU624
|
4.7
|
17.8
|
1.0
|
CA
|
B:ASN663
|
4.8
|
12.3
|
1.0
|
CB
|
B:ASN663
|
4.8
|
15.4
|
1.0
|
O
|
B:GLY659
|
4.9
|
21.3
|
1.0
|
CA
|
B:VAL629
|
4.9
|
11.8
|
1.0
|
C
|
B:LEU630
|
4.9
|
15.3
|
1.0
|
CG
|
B:TYR662
|
4.9
|
16.2
|
1.0
|
CG
|
B:PHE623
|
5.0
|
12.3
|
1.0
|
|
Potassium binding site 5 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 5 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 5 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:K801
b:31.9
occ:1.00
|
O
|
C:ASP612
|
2.5
|
30.7
|
1.0
|
O
|
C:LEU634
|
2.7
|
34.5
|
1.0
|
O
|
C:HIS614
|
2.7
|
33.2
|
1.0
|
OG
|
C:SER633
|
2.8
|
37.5
|
1.0
|
OD1
|
C:ASP610
|
2.8
|
31.6
|
1.0
|
O
|
C:ASP610
|
2.9
|
30.7
|
1.0
|
CG
|
C:ASP610
|
3.3
|
34.5
|
1.0
|
C
|
C:ASP610
|
3.5
|
32.2
|
1.0
|
C
|
C:ASP612
|
3.6
|
30.5
|
1.0
|
C
|
C:HIS614
|
3.7
|
34.4
|
1.0
|
C
|
C:LEU634
|
3.7
|
36.5
|
1.0
|
CB
|
C:ASP610
|
3.8
|
30.6
|
1.0
|
N
|
C:ASP612
|
3.8
|
25.9
|
1.0
|
N
|
C:LEU634
|
3.9
|
36.4
|
1.0
|
CB
|
C:HIS635
|
3.9
|
35.2
|
1.0
|
CB
|
C:SER633
|
4.0
|
38.0
|
1.0
|
OD2
|
C:ASP610
|
4.0
|
34.1
|
1.0
|
CA
|
C:ASP612
|
4.2
|
26.6
|
1.0
|
C
|
C:TRP611
|
4.2
|
29.1
|
1.0
|
N
|
C:TRP611
|
4.2
|
27.8
|
1.0
|
CA
|
C:HIS615
|
4.3
|
34.9
|
1.0
|
ND1
|
C:HIS635
|
4.3
|
40.5
|
1.0
|
CA
|
C:ASP610
|
4.3
|
28.5
|
1.0
|
CB
|
C:ASP612
|
4.3
|
28.0
|
1.0
|
CA
|
C:SER633
|
4.3
|
35.8
|
1.0
|
N
|
C:HIS614
|
4.4
|
29.8
|
1.0
|
N
|
C:HIS615
|
4.4
|
33.7
|
1.0
|
CA
|
C:TRP611
|
4.4
|
27.3
|
1.0
|
O
|
C:HOH919
|
4.4
|
21.1
|
1.0
|
CA
|
C:HIS635
|
4.4
|
34.3
|
1.0
|
N
|
C:HIS635
|
4.5
|
34.6
|
1.0
|
C
|
C:SER633
|
4.5
|
40.4
|
1.0
|
CA
|
C:LEU634
|
4.5
|
35.2
|
1.0
|
N
|
C:GLY616
|
4.6
|
35.9
|
1.0
|
CG
|
C:HIS635
|
4.6
|
38.5
|
1.0
|
C
|
C:VAL613
|
4.6
|
32.8
|
1.0
|
CA
|
C:HIS614
|
4.7
|
30.4
|
1.0
|
N
|
C:VAL613
|
4.7
|
27.0
|
1.0
|
OH
|
C:TYR631
|
4.8
|
39.1
|
1.0
|
CE1
|
C:HIS573
|
4.8
|
32.8
|
1.0
|
C
|
C:HIS615
|
4.8
|
38.0
|
1.0
|
ND1
|
C:HIS573
|
4.8
|
33.4
|
1.0
|
O
|
C:TRP611
|
4.9
|
28.1
|
1.0
|
|
Potassium binding site 6 out
of 6 in 8cj7
Go back to
Potassium Binding Sites List in 8cj7
Potassium binding site 6 out
of 6 in the HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor
Mono view
Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 6 of HDAC6 Selective Degraded (Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:K802
b:53.1
occ:1.00
|
O
|
C:VAL629
|
2.6
|
45.4
|
1.0
|
O
|
C:PHE623
|
2.6
|
54.4
|
1.0
|
O
|
C:ASP626
|
2.8
|
57.7
|
1.0
|
O
|
C:HOH909
|
2.9
|
32.9
|
1.0
|
O
|
C:TYR662
|
2.9
|
49.8
|
1.0
|
CB
|
C:TYR662
|
3.6
|
52.9
|
1.0
|
C
|
C:PHE623
|
3.6
|
53.3
|
1.0
|
C
|
C:TYR662
|
3.6
|
53.6
|
1.0
|
CB
|
C:PHE623
|
3.7
|
46.1
|
1.0
|
C
|
C:VAL629
|
3.8
|
46.6
|
1.0
|
C
|
C:ASP626
|
3.9
|
57.5
|
1.0
|
CA
|
C:TYR662
|
4.2
|
51.4
|
1.0
|
CA
|
C:PHE623
|
4.3
|
46.3
|
1.0
|
N
|
C:TYR631
|
4.4
|
40.6
|
1.0
|
N
|
C:ASP626
|
4.5
|
54.9
|
1.0
|
N
|
C:ASN663
|
4.5
|
51.6
|
1.0
|
CB
|
C:ASP626
|
4.5
|
54.4
|
1.0
|
CA
|
C:ASP626
|
4.5
|
53.7
|
1.0
|
N
|
C:GLU624
|
4.5
|
51.1
|
1.0
|
CA
|
C:LEU630
|
4.6
|
43.2
|
1.0
|
N
|
C:LEU630
|
4.7
|
43.7
|
1.0
|
CB
|
C:TYR631
|
4.7
|
39.8
|
1.0
|
CA
|
C:GLU624
|
4.7
|
52.3
|
1.0
|
O
|
C:GLU624
|
4.8
|
57.9
|
1.0
|
O
|
C:GLY659
|
4.8
|
65.2
|
1.0
|
C
|
C:GLU624
|
4.8
|
58.3
|
1.0
|
CA
|
C:VAL629
|
4.8
|
42.3
|
1.0
|
CG
|
C:TYR662
|
4.9
|
54.5
|
1.0
|
CA
|
C:ASN663
|
4.9
|
50.8
|
1.0
|
CB
|
C:ASN663
|
4.9
|
52.0
|
1.0
|
C
|
C:LEU630
|
4.9
|
44.6
|
1.0
|
CG
|
C:PHE623
|
5.0
|
45.3
|
1.0
|
|
Reference:
L.Ripa,
J.Sandmark,
G.Hughes,
I.Shamovsky,
A.Gunnarsson,
J.Johansson,
A.Llinas,
M.Collins,
B.Jung,
A.Noven,
N.Pemberton,
M.Mogemark,
Y.Xiong,
Q.Li,
S.Tangefjord,
M.Ek,
A.Astrand.
Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism. J.Med.Chem. 2023.
ISSN: ISSN 0022-2623
PubMed: 37797307
DOI: 10.1021/ACS.JMEDCHEM.3C01269
Page generated: Mon Aug 12 22:55:55 2024
|